Feasibility of Endoscopic Ultrasound Based Biliary Stone Removal Without Fluoroscopy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01678391|
Recruitment Status : Completed
First Posted : September 5, 2012
Last Update Posted : July 26, 2016
|Condition or disease||Intervention/treatment||Phase|
|Common Bile Duct Gall Stones||Procedure: Common bile duct stone removal without fluoroscopy.||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||33 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Feasibility of Endoscopic Ultrasound Based Biliary Stone Removal Without Fluoroscopy|
|Study Start Date :||August 2012|
|Actual Primary Completion Date :||June 2015|
|Actual Study Completion Date :||March 2016|
Experimental: Patients with common bile duct stones.
Common bile duct stone removal without fluoroscopy
Procedure: Common bile duct stone removal without fluoroscopy.
ERCP stone extraction technique without fluoroscopy involves: (1) catheter or catheter with wire access into the bile duct, (2) confirmation of biliary access with catheter aspiration of bile, (3) performance of endoscopic biliary sphincterotomy or balloon dilation to widen the bile duct opening to permit stone removal, (4) stone removal - number of stones seen on EUS should match the number removed.
- Successful removal of all stones from the bile duct without the use of fluoroscopy. [ Time Frame: Up to 24 hours. ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01678391
|United States, California|
|California Pacific Medical Center|
|San Francisco, California, United States, 94115|
|Principal Investigator:||Janak Shah, MD||California Pacific Medical Center|